Hamed Javan MD

Jewish General Hospital

Dr Javan is a medical doctor, completed Master of Experimental Medicine-Oncology program at McGill University, and working as clinical/research at the Jewish General Hospital with Dr Petr Kavan and Dr Gerald Batist. Dr Javan has established a phase II clinical trial for pancreatic cancer. He has a high interest toward investigator-initiated studies, and running new study protocols. Currently, he is preparing new studies in phase II, III and IV for Pancreatic and Colorectal Cancer. His particular research interest is: Pre—operative FOLFIRINOX in pancreatic cancer.

dont miss

Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer

Pancreatic Cancer is a disease with poor prognosis. In 2017, its 5-year net survival rate is only 8% with only 2% in metastatic setting and it is third common cause of cancer related death. Only less than 20% of cases are eligible for surgery at diagnosis, so we tried to evaluate the role preoperative FOLFIRINOX in potentially curable pancreatic cancer in retrospective study and clinical trial.

Hamed Javan MD will be speaking in the following theatre:

Theatre 11 - Tuesday 13.15 - 13.45: Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer

Theatre 11 - Wednesday 11.45 - 12.15: Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer

EVEN MORE SEMINARS

  • Stefan Schuster: Speaking at the Oncology Convention

    Stefan Schuster
    Datar Cancer Genetics Limited

    Clinical Utility of Liquid Biopsy in Brain Tumors

  • Dr. Anna ME Bruynzeel: Speaking at the Oncology Convention

    Dr. Anna ME Bruynzeel
    Amsterdam UMC (formerly VUmc)

    MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

  • Dr. Matthew Prime: Speaking at the Oncology Convention

    Dr. Matthew Prime
    Roche Diagnostics Information Solutions

    Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • Kate Casey: Speaking at the Oncology Convention

    Kate Casey
    The Leeds Gamma Knife Centre

    ICON LEKSELL GAMMA KNIFE STEREOTACTIC RADIOSURGERY